Feng L Z, Huang Q R, Yang W Z
School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Jun 6;56(6):861-863. doi: 10.3760/cma.j.cn112150-20220211-00125.
The COVID-19 continues to spread throughout the world, and local clusters and outbreaks related to overseas imports have occurred in many places in China. Vaccination against COVID-19 is one of the most effective tools to prevent disease, severe illness and death. For vaccines developed and used by China, it is particularly important for scientific and targeted prevention and control to study different outbreak scenarios, to conduct in-depth real-world research on SARS-CoV-2 variants, and to further promote vaccine development and technical reserves. This article commented the effectiveness of COVID-19 vaccine, and prospected the future research on vaccine efficacy, immunization strategy and vaccine development, which provided evidence for optimizing vaccination strategy.
新型冠状病毒肺炎(COVID-19)仍在全球持续传播,中国多地出现了与境外输入相关的局部聚集性疫情。接种COVID-19疫苗是预防疾病、重症和死亡的最有效手段之一。对于我国研发和使用的疫苗而言,研究不同的疫情情景,深入开展严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株的真实世界研究,进一步推进疫苗研发和技术储备,对于科学精准防控尤为重要。本文对COVID-19疫苗的有效性进行了述评,并对疫苗效力、免疫策略及疫苗研发的未来研究进行了展望,为优化接种策略提供依据。